Name | ((1S,4aR,6S,7S,7aS)-6-acetoxy-7-(chloromethyl)-4a,7-dihydroxy-1-((3-methylbutanoyl)oxy)-1,4a,5,6,7,7a-hexahydrocyclopenta[c]pyran-4-yl)methyl (R)-3-methyl-2-((3-methylbutanoyl)oxy)butanoate |
---|---|
Synonyms |
Butanoic acid, 3-methyl-2-(3-methyl-1-oxobutoxy)-, [(1S,4aR,6S,7S,7aS)-6-(acetyloxy)-7-(chloromethyl)-1,4a,5,6,7,7a-hexahydro-4a,7-dihydroxy-1-(3-methyl-1-oxobutoxy)cyclopenta[c]pyran-4-yl]methyl ester, (2R)-
{(1S,4aR,6S,7S,7aS)-6-Acetoxy-7-(chloromethyl)-4a,7-dihydroxy-1-[(3-methylbutanoyl)oxy]-1,4a,5,6,7,7a-hexahydrocyclopenta[c]pyran-4-yl}methyl (2R)-3-methyl-2-[(3-methylbutanoyl)oxy]butanoate |
Description | Volvaltrate B is an anticancer agent, iridoid, can be obtained from the root of valerian (Valeriana officinalis). Volvaltrate B is effective against ovarian tumors in female mice. Volvaltrate B has the potential to study cancer[1][2]. |
---|---|
Related Catalog | |
References |
Density | 1.3±0.1 g/cm3 |
---|---|
Boiling Point | 632.3±55.0 °C at 760 mmHg |
Molecular Formula | C27H41ClO11 |
Molecular Weight | 577.06 |
Flash Point | 336.2±31.5 °C |
Exact Mass | 576.233765 |
PSA | 154.89000 |
LogP | 3.13 |
Vapour Pressure | 0.0±4.2 mmHg at 25°C |
Index of Refraction | 1.526 |
Hazard Codes | Xi |
---|